| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |